Learn more

VERIDEX LLC

Overview
  • Total Patents
    419
  • GoodIP Patent Rank
    194,475
  • Filing trend
    0.0%
About

VERIDEX LLC has a total of 419 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2000. It filed its patents most often in Canada, China and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are NCC TECHNOLOGY VENTURES PTE LT, ZEUS SCIENTIFIC INC and OBERBAUER RAINER.

Patent filings per year

Chart showing VERIDEX LLCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wang Yixin 94
#2 Mazumder Abhijit 61
#3 Raponi Mitch 51
#4 Rao Galla Chandra 36
#5 Zhang Yi 31
#6 Terstappen Leon W M M 31
#7 Vener Tatiana 29
#8 Connelly Mark Carle 26
#9 Belly Robert 26
#10 Backus John 25

Latest patents

Publication Filing date Title
TW201311907A Genomic diagnostics using circulating endothelial cells
AU2012202170A1 Prognostic for hematological malignancy
CA2814528A1 Methods and kits for the detection of circulating tumor cells in pancreatic patients using polyspecific capture and cocktail detection reagents
JP2012022002A Method of predicting progression-free and overall survival of metastatic breast cancer patient at each point of follow-up period using circulating tumor cell
CN103328971A Methods of determining acute myeloid leukemia response to treatment with farnesyltransferase inhibitors
TW201205079A A method of predicting clinical outcomes for melanoma patients using circulating melanoma cells in blood
WO2011143075A2 A simple and affordable method for immuophenotyping using a microfluidic chip sample preparation with image cytometry
WO2011123615A1 Gene-based prediction of psa recurrence for clinically localized prostate cancer patients
WO2011002649A1 Analysis of circulating tumor-related microparticles
WO2010091304A1 A filter method for separating ferrofluids in a biological sample
JP2010019850A Magnetic separator and method thereof
CN102308003A Prostate cancer methylation assay
EP2283161A2 Methods for assessing colorectal cancer and compositions for use therein
CA2717975A1 A method for detecting igf1r/chr 15 in circulating tumor cells using fish.
KR20100120657A Molecular staging of stage ii and iii colon cancer and prognosis
MX2010008009A Detection of gstp1 hypermethylation in prostate cancer.
CA2709395A1 Copy number alterations that predict metastatic capability of human breast cancer
BRPI0820557A2 Diagnostic biomarkers of diabetes
CN101878313A Process for predicting the prognosis of squamous cell lung cancer
KR20100093539A Process for monitoring colorectal cancer